Clal Biotech(IL:CBI)
ILA 21.10-0.80 (-3.65%)
IL:CBI
Clal Biotech financials statements
ILA 21.10
At close:-0.80 (-3.65%)
Clal Biotech (CBI) Income Statement
0 Followers
Clal Biotech Income Statement
Last quarter (Q2 2026), Clal Biotech's total revenue was ₪638.50K. In Q2, Clal Biotech's net income was ₪-2.94M. See Clal Biotech’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ₪ 835.00K | ₪ 433.00K | ₪ 104.00K | ₪ 370.00K | ₪ 224.00K | |
| ₪ 364.00K | ₪ -183.00K | ₪ 104.00K | ₪ 370.00K | ₪ 224.00K | |
| ₪ 18.78M | ₪ 6.34M | ₪ 10.29M | ₪ 12.27M | ₪ 77.47M | |
| Depreciation and Amortization | ₪ 216.00K | ₪ 283.00K | ₪ 526.00K | ₪ 17.64M | ₪ 22.51M |
| ₪ -19.83M | ₪ -6.34M | ₪ -24.02M | ₪ 64.22M | ₪ -55.08M | |
| ₪ -18.41M | ₪ -6.34M | ₪ -10.18M | ₪ -27.42M | ₪ -77.59M | |
| ₪ -1.76M | ₪ -68.73M | ₪ -17.91M | ₪ -13.61M | ₪ 11.00M | |
| ₪ -20.17M | ₪ -75.07M | ₪ -28.09M | ₪ -41.02M | ₪ -66.59M | |
| ₪ -13.32M | ₪ -62.46M | ₪ -31.05M | ₪ -61.74M | ₪ -89.58M | |
| Per Share Metrics | |||||
| Basic EPS | ₪ -0.08 | ₪ -0.40 | ₪ -0.20 | ₪ -0.39 | ₪ -0.57 |
| Diluted EPS | ₪ -0.08 | ₪ -0.40 | ₪ -0.20 | ₪ -0.39 | ₪ -0.57 |
| Weighted Average Shares Outstanding | 156.85M | 158.44M | 156.85M | 156.85M | 158.44M |
| Weighted Average Shares Outstanding (Diluted) | 156.85M | 158.44M | 156.85M | 156.85M | 158.44M |
Currency in ILS
